» Articles » PMID: 37783685

Multifaceted Analysis of Cross-tissue Transcriptomes Reveals Phenotype-endotype Associations in Atopic Dermatitis

Abstract

Atopic dermatitis (AD) is a skin disease that is heterogeneous both in terms of clinical manifestations and molecular profiles. It is increasingly recognized that AD is a systemic rather than a local disease and should be assessed in the context of whole-body pathophysiology. Here we show, via integrated RNA-sequencing of skin tissue and peripheral blood mononuclear cell (PBMC) samples along with clinical data from 115 AD patients and 14 matched healthy controls, that specific clinical presentations associate with matching differential molecular signatures. We establish a regression model based on transcriptome modules identified in weighted gene co-expression network analysis to extract molecular features associated with detailed clinical phenotypes of AD. The two main, qualitatively differential skin manifestations of AD, erythema and papulation are distinguished by differential immunological signatures. We further apply the regression model to a longitudinal dataset of 30 AD patients for personalized monitoring, highlighting patient heterogeneity in disease trajectories. The longitudinal features of blood tests and PBMC transcriptome modules identify three patient clusters which are aligned with clinical severity and reflect treatment history. Our approach thus serves as a framework for effective clinical investigation to gain a holistic view on the pathophysiology of complex human diseases.

Citing Articles

Unveiling novel susceptibility genes and drug targets for basal cell carcinoma by a cross-tissue transcriptome-wide association study.

Sun H, Li L, Xin X, Yan J, Huang T Discov Oncol. 2025; 16(1):288.

PMID: 40063313 PMC: 11893943. DOI: 10.1007/s12672-025-02019-y.


Blocking the IL-4/IL-13 Axis versus the JAK/STAT Pathway in Atopic Dermatitis: How Can We Choose?.

Calabrese L, DOnghia M, Lazzeri L, Rubegni G, Cinotti E J Pers Med. 2024; 14(7).

PMID: 39064029 PMC: 11278138. DOI: 10.3390/jpm14070775.


Genome-wide identification of dysregulated alternative splicing and RNA-binding proteins involved in atopic dermatitis.

Yang Y, Chen H, Jiang Q, Yang L, Zhu R, Huang N Front Genet. 2024; 15:1287111.

PMID: 38495671 PMC: 10940350. DOI: 10.3389/fgene.2024.1287111.

References
1.
Regev A, Teichmann S, Lander E, Amit I, Benoist C, Birney E . The Human Cell Atlas. Elife. 2017; 6. PMC: 5762154. DOI: 10.7554/eLife.27041. View

2.
Mobus L, Rodriguez E, Harder I, Stolzl D, Boraczynski N, Gerdes S . Atopic dermatitis displays stable and dynamic skin transcriptome signatures. J Allergy Clin Immunol. 2020; 147(1):213-223. DOI: 10.1016/j.jaci.2020.06.012. View

3.
Khattri S, Brunner P, Garcet S, Finney R, Cohen S, Oliva M . Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis. Exp Dermatol. 2016; 26(1):28-35. PMC: 5502835. DOI: 10.1111/exd.13112. View

4.
Kozawa S, Ueda R, Urayama K, Sagawa F, Endo S, Shiizaki K . The Body-wide Transcriptome Landscape of Disease Models. iScience. 2018; 2:238-268. PMC: 6135982. DOI: 10.1016/j.isci.2018.03.014. View

5.
Imai Y, Kusakabe M, Nagai M, Yasuda K, Yamanishi K . Dupilumab Effects on Innate Lymphoid Cell and Helper T Cell Populations in Patients with Atopic Dermatitis. JID Innov. 2021; 1(1):100003. PMC: 8659712. DOI: 10.1016/j.xjidi.2021.100003. View